News Conference News ACC 2024 Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI Shelley Wood April 06, 2024
News Conference News ACC 2023 Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA Yael L. Maxwell March 09, 2023
News Conference News ACC 2022 Managing AF Patients Undergoing PCI—Some Lingering Questions Michael O'Riordan April 12, 2022
News Conference News ACC 2018 Loading Dose Smooths Switch From Ticagrelor to Clopidogrel After PCI: SWAP-4 Yael L. Maxwell March 19, 2018
News Conference News ACC 2018 Too Soon for 6-Month DAPT, Say SMART-DATE Investigators, Despite Positive Trial Yael L. Maxwell March 12, 2018
News Conference News ACC 2018 Genetic Testing Influences Post-PCI Antiplatelet Prescriptions, but Other Factors Also Play a Role Yael L. Maxwell March 11, 2018
News Conference News ACC 2018 Reducing Co-payments for P2Y12 Inhibitors Upped Ticagrelor Use but Didn’t Budge MACE: ARTEMIS Caitlin E. Cox March 11, 2018
News Conference News ACC 2018 ACC 2018, Day Two: Antiplatelets in ACS, Dabigatran in Noncardiac Surgery, and More Shelley Wood March 11, 2018
News Conference News ACC 2016 More Evidence That Morphine Hampers Effects of Antiplatelet Therapy in STEMI Todd Neale April 02, 2016
News Conference News ACC 2015 Long-Term DAPT with Ticagrelor Reduces Ischemic Risk, Ups Bleeding in MI Patients Todd Neale March 14, 2015
News Conference News ACC 2012 ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released Yael L. Maxwell April 02, 2012